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Dr Marc de Perrot (Toronto, Ontario, Canada). Dr Bolton,
that was a very nice presentation and I would like to congratulate
you and your colleagues from MD Anderson for reporting on this
very challenging group of patients.
Spinal resection for non–small cell lung cancer has now been re-
ported by several groups with good results and is certainly the best
option for a carefully well-selected group of patients.
In Toronto we have done about 25 hemivertebrectomy and
a handful of total vertebrectomy for non–small cell lung cancer in-
volving the spine. Although I don’t want to spend too much time
describing our results, I think it is important to emphasize that
our approach has been different than the one from MD Anderson
in the sense that we have used induction chemoradiation therapy
for all of our patients and have completed the resection en bloc be-
tween the lung and the spine. The approach you have just presented
has been primarily surgery with an intralesional resection of the tu-
mor rather than an en bloc resection, as you mentioned. This differ-
ence probably results from the fact that you have been working with
neurosurgeons, whereas we have been working with orthopedists
primarily. However, I think when comparing the two approaches,
it is important to make sure that you are comparing the same group
of patients.
As you described, there are several types of spinal resections
with different magnitudes of surgery that can be required for tumors1386 The Journal of Thoracic and Cardiovascular Suinvading the spine. Resection of the transverse process or wedge re-
section of the edge of the vertebral body that was mainly presented
in your groups 1 and 2 are less extensive than the hemivertebrec-
tomy or total vertebrectomy that you have included in group 3.
The spinal resection for group 1 and 2 can usually be done through
the same incision as the lung resection and there is usually no need
for any spinal reconstruction. When a hemivertebrectomy or total
vertebrectomy is performed at the level of T1, it requires an anterior
and a posterior approach in order to completely remove the tumor
en bloc with the spine and to achieve adequate reconstruction of the
spine.
In your presentation, you have included patients with involve-
ment of the neuroforamen along with patients who had involve-
ment of the transverse process in the same group. I don’t think
these two groups of patients are similar, at least in our experience.
In our practice, patients with involvement of the neuroforamen
would usually have an en bloc hemivertebrectomy with the lung re-
section in order to be able to section the nerve root inside the spinal
canal and achieve complete resection. This would then be followed
by spinal stabilization. Patients with involvement of the transverse
process otherwise would have resection of the transverse process
with the chest wall resection and would not require any type of spi-
nal stabilization.
So my first question is, how many patients in your first group had
involvement of the neuroforamen versus involvement of the trans-
verse process and how many patients required spinal stabilization
in that specific group of patients?
Dr Bolton. Thank you for your comments and question.
I think that your question is how many patients in group 1, 8 pa-
tients, had neuroforamen involvement by itself or transverse process
by itself. We did not break that group into a smaller group. There
were only 8 of those. So I don’t have the information of which
ones had just neuroforamen involvement. I do know that none of
those patients had to have a spinal stabilization for their resection.
Dr de Perrot. My second question relates to the surgical resec-
tion margins. You mentioned that 44% of your patients had a posi-
tive resection margin, which is higher than what has been reported
in other series. This may be due to the fact that you have included
only patients with superior sulcus tumors. However, considering
that you do not attempt to do an en bloc resection but perform an
intralesional resection, I’m wondering how you could interpret
the surgical margin for patients who did not have en bloc resection.
Dr Bolton. Again, I believe your question is how do we assess
the surgical margin in the operating room during the operation.
With that, on the total vertebrectomies, we assess the margins by
taking the soft tissues around the vertebral body that we have re-
sected, and that can be done at the time of the operation. On patients
with a partial vertebrectomy, obviously we can’t send bone for a fro-
zen section, and so we would use the high-speed drill to drill
through to bone that appeared normal and then take samples of
that and send that for a permanent section. So that’s how we as-
sessed our margins.
Dr de Perrot. So if the final specimen was negative, that was
your negative margin?
Dr Bolton.But that would come back on a final pathologic spec-
imen. We would not have that information during the operation. On
the partial vertebrectomies, we would do it to grossly normal-ap-
pearing bone.rgery c June 2009
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SDr de Perrot. My last question relates to the group of patients
who had total vertebrectomy. You mentioned 15 patients in that
group, which is certainly the largest experience reported in the lit-
erature. Looking more specifically at that group of patients, you re-
ported an R0 resection rate of about 50%, with a local recurrence
rate of about 40%, and a 5-year survival of 22%. Again, I think
this is certainly the most difficult group of patients to manage be-
cause of the morbidity that the tumor by itself will create if it is
not controlled locally and because of the complexity of performing
a surgical resection in these patients. My last question is, among all
15 total vertebrectomies that you have done, were all these patients
treated with a curative intent or were some of them treated to
achieve primarily local control? Along the same line, you men-
tioned that 11 patients had a wedge resection rather than a more for-
mal lobectomy, and I would be interested to know if these 11
patients were more specifically in that group of patients who had
a total vertebrectomy.
Dr Bolton. We did not look at how many patients in the total
vertebrectomy group had a wedge resection versus a lobectomy
versus a pneumonectomy, so I can’t give you that answer.
What was the rest of your question?
Dr de Perrot. I’m just wondering whether all these patients
were operated on with a curative intent or were some of them un-
dergoing surgery rather to achieve local control because of the mor-
bidity of these tumors.
Dr Bolton. Yes, there were 4 patients in our study that we did
a palliative resection on. Again, I don’t know exactly where all 4
of those are. Some of those were in the total vertebrectomy group,
but not all of them.
Dr de Perrot. Thank you.
Dr Bolton. Thank you for your questions.
Dr Frank C. Detterbeck (NewHaven, Conn). How do you pre-
operatively stage the patients, nodal staging?
Dr Bolton. How many were preoperatively staged, is that the
question?
Dr Detterbeck. Well, how do you stage them? Do you do me-
diastinoscopy? Do you do PET? What do you do?
Dr Bolton. This was over a long period of time, and so the op-
timal staging for mediastinal.
Dr Detterbeck. What do you think it should be now, given your
experience?
Dr Bolton. Well, given our experience, with the fact that we
found no patients with a positive node either in stations 1, 2, or 3
that lived more than 23 months, I think that if you’re going to do
surgery for this group of patients, you need to adequately stage
the mediastinum with mediastinoscopy or EBUS. With EBUS
you have the ability to maybe stage more than just the mediastinum
and stage levels 10 and 11 lymph nodes, and so that would be an
additional benefit to use EBUS in this patient population.
DrDetterbeck. The second question has to do with the high rate
of incomplete resection. What do you think we can do to improve
that? Certainly preoperative chemoradiotherapy in Pancoast tumors
in general has resulted in a much higher rate of complete resection.The Journal of Thoracic and CDo you think that that is the answer? The other related question is
selection. What criteria do you have to make you say this patient is
not resectable; there is either too much vertebral body involvement,
there’s involvement of the dura, there’s some other aspect of what
contributes to a positive margin that makes that patient not a good
candidate?
Dr Bolton. Thank you for your question.
Looking at the assessment of whether or not we will be able to
get the patient resected, there have been a couple of studies that
have looked at using preoperative imaging, such as MRI, to sort
of help determine whether or not you could be more successful.
Unfortunately, those studies did not show a difference on any of
their definitions of how much vertebral body involvement was
found preoperatively. I don’t think that we have a good imaging
modality to help us with that. Certainly if you had a patient with
multiple vertebral bodies destroyed by tumor, that would be an
easy patient to say that you could not do it on, but otherwise I
don’t think the imaging available currently can tell us that on the
minor points.
Dr Dominique Grunenwald (Paris, France). I was extremely
anxious to discover the late results of the MDA’s multidisciplinary
approach, since we presented at this meeting here in San Diego in
year 2001 the initial part of our series of en bloc resection for non–
small cell lung cancer attached to the spine. Interestingly, our up-
dated data, despite the difference in our respective approaches,
show similar results now. The differences are in the surgical proce-
dures, as we performed an en bloc resection in all cases. Secondly,
the extent of resection is quite different, because our series includes
a large majority of partial resections, of hemivertebrectomies (28
among 34 patients). Thirdly, the complete resection rate that we
achieved was 90% compared to your 56% of complete resections.
Nevertheless, results in terms of long-term survival, 5-year sur-
vival, are absolutely the same, because we achieved a 24% 5-
year survival now compared to your 27% survival. But we didn’t
include the patients with only a transverse or foraminal involve-
ment. So our results and these comments confirm your conclusions,
Dr Bolton. Congratulations.
Dr Bolton. Thank you very much, sir.
Dr Alain Chapelier (Paris, France). Congratulations on this
impressive series of very difficult patients requiring demanding sur-
gical strategies. I have a comment and a short question. Earlier this
year, Philippe Dartevelle and colleagues reported the long-term re-
sults of surgery of superior sulcus tumors with 28% 5-year survival
in the group of patients with en bloc resection, partial vertebrec-
tomy. However, this tumor was only extending into the intraforami-
nal process. So my question is, considering the poor survival of the
subset of patients with positive margins, wouldn’t you be reluctant
to consider such extended surgery if you don’t have a strong prob-
ability of achieving a complete resection?
Dr Bolton. Thank you for your question.
Looking at our data, I would say that it would be much better to
be able to get a negative margin on your resection. So, yes, we
would much prefer to be able to get a negative margin.ardiovascular Surgery c Volume 137, Number 6 1387
